Santulli, Gaetano

Update on peripheral artery disease: Epidemiology and evidence-based facts

Shu, J., & Santulli, G. (2018) · Atherosclerosis

Peripheral Artery Disease ManagementDiabetic Foot Ulcer Assessment and Management

Cited by 487

Angiopoietin-Like Proteins: A Comprehensive Look

Santulli, G. (2014) · Frontiers in Endocrinology

Lipid metabolism and disordersAngiogenesis and VEGF in Cancer

Cited by 320

Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging

Umanskaya, A., Santulli, G., Xie, W., Andersson, D. C., Reiken, S. R., & Marks, A. R. (2014) · Proceedings of the National Academy of Sciences

Mitochondrial Function and PathologyMuscle Physiology and Disorders

Cited by 157

Tirzepatide: A Systematic Update

Forzano, I., Varzideh, F., Avvisato, R., Jankauskas, S. S., Mone, P., & Santulli, G. (2022) · International Journal of Molecular Sciences

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 118

Choline supplements: An update

Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., & Santulli, G. (2023) · Frontiers in Endocrinology

Neuroprotection in Cerebral IschemiaCholinesterase and Neurodegenerative Diseases

Cited by 103

Adrenergic receptors and metabolism: role in development of cardiovascular disease

Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B., & Iaccarino, G. (2013) · Frontiers in Physiology

Receptor Mechanisms and SignalingCardiovascular Function and Risk Factors

Cited by 89

Pathophysiological mechanisms underlying the beneficial effects of physical activity in hypertension

Gambardella, J., Morelli, M. B., Wang, X., & Santulli, G. (2020) · The Journal of Clinical Hypertension

Cardiovascular and exercise physiologyBlood Pressure and Hypertension Studies

Cited by 54

Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes

Kansakar, U., Jankauskas, S. S., Pande, S., Mone, P., Varzideh, F., & Santulli, G. (2026) · International Journal of Molecular Sciences

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 22

The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts

Varzideh, F., Kansakar, U., Wilson, S., Jankauskas, S. S., & Santulli, G. (2024) · Cell Cycle

Cardiac Fibrosis and RemodelingDiabetes Treatment and Management

Cited by 10